| Lokomat group (n = 15) | Control group (n = 15) | ||
---|---|---|---|---|
 | Mean ± S.D. | Range | Mean ± S.D. | Range |
Age (y) | 50.80 ± 2.12 | 37–70 | 44.65 ± 2.66 | 25–62 |
Lesion duration (y) | 11.80 ± 2.54 | 2–36 | 8.09 ± 1.89 | 1–27 |
WISCI II (range, 0–20) | 15.33 ± 1.12 | 9–20 | 14.20 ± 1.47 | 9–20 |
TUG (s) | 34.2 ± 9.6 | 9.7–126.1 | 39.7 ± 6.76 | 8.7–95.0 |
10MWT (m/s) | 0.56 ± 0.09 | 0.05–1.06 | 0.56 ± 0.11 | 0.09–1.49 |
6MWT (m) | 207.0 ± 29.6 | 25.5–346.0 | 205.6 ± 35.3 | 25.9–501.2 |
Sex †(F - M) | 7 (46.67%) - 8 (53.33%) | 1 (6.67%) - 14 (93.33%) |  |  |
Level of lesion †(C [C2-C7] – T [T1-T7]) | 11 (60) - 4 (40) | 9 (73.33) - 6 (26.67) |  |  |
Ankle flexors MAS ‡ (range, 0–4) | 2 (IQR = 1) | 2 (IQR = 1) |  |  |